Publications by authors named "Heidrun Engler"

Claim this Profile
C
Characterization of hemodynamic events following intravascular infusion of recombinant adenovirus reveals possible solutions for mitigating cardiovascular responses.
Todd Machemer, Heidrun Engler, Van Tsai, Seoju Lee, Susan Cannon-Carlson

Mol Ther· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained intravesical interferon protein exposure is achieved using an adenoviral-mediated gene delivery system: a study in rats evaluating dosing regimens.
Robert J Connor, Jennifer M Anderson, Todd Machemer, Daniel C Maneval, Heidrun Engler

Urology· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclodextrin-modified polyethylenimine polymers for gene delivery.
Suzie H Pun, Nathalie C Bellocq, Aijie Liu, Greg Jensen, Todd Machemer, Heidrun Engler

Bioconjug Chem· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute hepatotoxicity of oncolytic adenoviruses in mouse models is associated with expression of wild-type E1a and induction of TNF-alpha.
Heidrun Engler, Todd Machemer, Jennifer Philopena, Shu-Fen Wen, Erlinda Quijano

Virology· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravesical Ad-IFNalpha causes marked regression of human bladder cancer growing orthotopically in nude mice and overcomes resistance to IFN-alpha protein.
William F Benedict, Ziming Tao, Chang-Soo Kim, Xinqiao Zhang, Jain-Hua Zhou, Heidrun Engler

Mol Ther· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacologic indicators of antitumor efficacy for oncolytic virotherapy.
G William Demers, Duane E Johnson, Van Tsai, Shu-Fen Wen, Erlinda Quijano, Heidrun Engler

Cancer Res· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a formulation that enhances gene expression and efficacy following intraperitoneal administration in rabbits and mice.
Heidrun Engler, Todd R Machemer, Thomas Schluep, Shu-Fen Wen, Erlinda Quijano

Mol Ther· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Syn3 provides high levels of intravesical adenoviral-mediated gene transfer for gene therapy of genetically altered urothelium and superficial bladder cancer.
Motoyuki Yamashita, Charles J Rosser, Jain-Hua Zhou, Xin-Qiao Zhang, Robert J Connor, Heidrun Engler

Cancer Gene Ther· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful adenovirus-mediated wild-type p53 gene transfer in patients with bladder cancer by intravesical vector instillation.
Jürgen Kuball, Shu Fen Wen, Joachim Leissner, Derek Atkins, Patricia Meinhardt, Heidrun Engler

J Clin Oncol· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis